Gemzar and disease progression 
Gemzar and disease progression Patient Reports February 13, 2012
Gemzar Side Effects Report #6097828-1
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 50 years of age, was diagnosed with synovial sarcoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, cholecystitis infective, disease progression, microangiopathic haemolytic anaemia, nephropathy toxic, petechiae, renal failure, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4614132-6
Gemzar side effect was reported by a Physician from on Mar 02, 2005. Female patient, 71 years of age, was diagnosed with sarcoma uterus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activities of daily living impaired, cyst, disease progression, disease recurrence, malignant neoplasm progression, metastases to bone, metastases to central nervous system, metastases to lymph nodes. Gemzar dosage: 800 MG/M2 OTHER. During the same period patient was treated with TAXOTERE, DEXAMETHASONE, GRANISETRON, METOCLOPRAMIDE, HS BLOCKER. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #5411945-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 01, 2007. Female patient, 66 years of age, weighting 121.3 lb, was diagnosed with pleural mesothelioma malignant, insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: decreased appetite, disease progression, inflammation, interstitial lung disease, pleural effusion, pneumonia
. Gemzar dosage: 1500 MG, OTHER. During the same period patient was treated with CISPLATIN, CARBOPLATIN, LENDORMIN, NAVELBINE. Patient recovered.Gemzar Side Effects Report #4724484-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on July 20, 2005. Female patient was diagnosed with pancreatic disorder and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activities of daily living impaired, asthenia, diarrhoea, disease progression, dizziness
, dysstasia, fall , fatigue. Gemzar dosage: unknown. During the same period patient was treated with OXALI, LAPATINIB. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5055322-0
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2006. Female patient, 56 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, jaundice cholestatic, malignant neoplasm progression, metastases to liver, metastases to lymph nodes, pancreatic carcinoma recurrent, pancreatic carcinoma stage iv, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient recovered.
Gemzar Side Effects Report #5929331-0
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 23, 2008. Male patient, 53 years of age, weighting 281.5 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain
, ascites, disease progression, nausea , palmar-plantar erythrodysaesthesia syndrome. Gemzar dosage: 760 MG/MG IV DAYS1 + 8. During the same period patient was treated with XELODA, METOCLOPRAMIDE, PRILOSEC, ASPIRIN, SIMVASTATIN, LISONPRIL, ALPRAZOLAM, LEXAPRO. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5941677-9
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Male patient, 53 years of age, weighting 281.5 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, disease progression, hepatic failure, palmar-plantar erythrodysaesthesia syndrome, pancreatic disorder, renal failure, respiratory failure. Gemzar dosage: 750 MG/MG IV DAYS1 + 8. During the same period patient was treated with XELODA, METROCLOPRAMIDE, PRILOSEC, ASPIRIN, SIMVASTATIN, LISONPRIL, ALPRAZOLAM, LEXAPRO. Patient was hospitalized. Patient died on 10/31/2008.
Gemzar Side Effects Report #5318946-9
Gemzar side effect was reported by a Physician from JAPAN on May 01, 2007. Male patient, 52 years of age, weighting 126.8 lb, was diagnosed with pancreatic carcinoma stage iv, diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, disease progression, haemoglobin decreased, nephritis interstitial, renal failure acute, small intestinal haemorrhage. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with GLIBENCLAMIDE. Patient died on 11/19/2002.
Gemzar Side Effects Report #4992756-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2005. Female patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, injection site irritation. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #4741457-6
Gemzar side effect was reported by a Physician from JAPAN on July 29, 2005. Female patient, 73 years of age, weighting 85.98 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, blood pressure systolic decreased, disease progression, pneumonia aspiration. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with LASIX, PURSENNID, SEROTONE, PICIBANIL. Patient died on 02/08/2003.
Gemzar Side Effects Report #6115177-X
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2008. Female patient, 71 years of age, weighting 105.8 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, renal failure acute. Gemzar dosage: unknown. During the same period patient was treated with SUNITINIB, XELODA. Patient was hospitalized. Patient died on 01/08/2008.
Gemzar Side Effects Report #4806796-9
Gemzar side effect was reported by a Physician from JAPAN on Sept 28, 2005. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain
, blood pressure increased, carbohydrate antigen 19-9 increased, disease progression, haematuria, haemolytic uraemic syndrome, hypocalcaemia, iron deficiency anaemia, marrow hyperplasia. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with RABEPRAZOLE, MUCOSTA, HARNAL, AMARYL. Patient recovered.Gemzar Side Effects Report #4919790-4
Gemzar side effect was reported by a Health Professional from JAPAN on Jan 27, 2006. Male patient, 69 years of age, weighting 50.60 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood culture positive, cerebral infarction, disease progression, dyslalia, dysphagia, dyspnoea, escherichia infection, malignant pleural effusion, muscular weakness. Gemzar dosage: 1600 MG, OTHER, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4596044-X
Gemzar side effect was reported by a Health Professional from on Feb 07, 2005. Male patient, 64 years of age, weighting 88.18 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, neutrophil count decreased, pyothorax, staphylococcal infection
, white blood cell count decreased. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with COSPANON, URSODIOL, MS CONTIN. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4681976-4
Gemzar side effect was reported by a Physician from on May 16, 2005. Male patient, 64 years of age, weighting 88.18 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, disease recurrence, pyothorax, pyrexia, staphylococcal infection
, white blood cell count decreased. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with COSPANON, URSODIOL, MS CONTIN. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4907048-9
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 24, 2006. Female patient, 60 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, pancreatic carcinoma, pulmonary embolism
. Gemzar dosage: unknown. Patient died on 12/01/2005.Gemzar Side Effects Report #5526551-4
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site infection, disease progression, hypersensitivity, malaise, malignant neoplasm progression, nausea
, weight decreased. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL, TAXOTERE, PANCREATIC ENZYMES. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5055323-2
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2006. Male patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain
, activities of daily living impaired, ascites, atelectasis, computerised tomogram abnormal, condition aggravated, depressed level of consciousness, disease progression, dyspnoea. Gemzar dosage: 1200 MG, INTRAVENOUS. During the same period patient was treated with KYTRIL, DECADRON #, RINDERON, ETODOLAC, PARIET, MUCOSTA, THEOLONG, SPIROPENT. Patient was hospitalized. Patient died on 05/11/2006.Gemzar Side Effects Report #4681600-0
Gemzar side effect was reported by a Health Professional from on May 17, 2005. Female patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alopecia, ascites, asthenia, blood albumin decreased, diarrhoea, disease progression, disorientation, hepatomegaly, hypotrichosis. Gemzar dosage: unknown. Patient died on 04/01/2005.
Gemzar Side Effects Report #5778092-7
Gemzar side effect was reported by a Physician from UNITED STATES on June 04, 2008. Male patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, haemorrhage, hepatic failure, platelet count decreased, pneumonia
, renal impairment, sepsis . Gemzar dosage: unknown. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient died on 06/05/2008.Gemzar Side Effects Report #4698483-5
Gemzar side effect was reported by a Physician from on June 02, 2005. Female patient, 51 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, gastric disorder, haemangioma, melaena. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #5337613-9
Gemzar side effect was reported by a Physician from UNITED STATES on May 18, 2006. Male patient, 50 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal symptom, disease progression, platelet count decreased. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #4562962-1
Gemzar side effect was reported by a Physician from on Dec 27, 2004. Male patient, 50 years of age, weighting 160.9 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aphagia, disease progression, oesophagitis, radiation oesophagitis. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with PRAVASTATIN, ENALAPRIL MALEATE, DIOVAN, FLUITRAN, ALLOPURINOL, AMLODIPINE BESYLATE, MORPHINE SULPHATE, PRIMPERAN ELIXIR. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4697537-7
Gemzar side effect was reported by a Health Professional from on June 06, 2005. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: biliary tract disorder, disease progression, obstruction, sepsis
. Gemzar dosage: 1800 MG. Patient died on 06/05/2005.Gemzar Side Effects Report #4703880-5
Gemzar side effect was reported by a Health Professional from on June 10, 2005. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bile duct obstruction, disease progression, sepsis
. Gemzar dosage: 1800 MG. Patient died on 06/05/2005.Gemzar Side Effects Report #4630505-X
Gemzar side effect was reported by a Health Professional from on Apr 05, 2005. Female patient, 48 years of age, weighting 120.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dehydration, depressed level of consciousness, disease progression. Gemzar dosage: 1000MG/M2 DAYS 1,8,15. During the same period patient was treated with DILAUDID. Patient died on 12/14/2004.
Gemzar Side Effects Report #5595965-9
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, gastroduodenal ulcer, gastrointestinal haemorrhage, neutropenia. Gemzar dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #5675284-2
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 07, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disease progression. Gemzar dosage: 1000 MG/M2. Patient recovered.
Gemzar Side Effects Report #6114819-2
Gemzar side effect was reported by a Health Professional from UNITED STATES on Feb 27, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, rash
. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient died on 01/11/2008.Gemzar Side Effects Report #6004375-1
Gemzar side effect was reported by a Physician from UNITED STATES on Dec 09, 2008. Female patient, 52 years of age, was diagnosed with ovarian cancer recurrent, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, disease progression, hypercalcaemia, malignant neoplasm progression, metastases to bone, spinal cord compression. Gemzar dosage: 1000 MG/M2, DAYS 1 AND 15. During the same period patient was treated with CISPLATIN, BEVACIZUMAB, ZOFRAN, DEXAMETHASONE, LORAZEPAM, METOCLOPRAMIDE, ATIVAN. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #6079362-8
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 13, 2009. Female patient, 52 years of age, was diagnosed with ovarian cancer recurrent, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, disease progression, hypercalcaemia, international normalised ratio increased, metastases to bone, spinal cord compression, thrombocytopenia. Gemzar dosage: 1000 MG/M2, DAYS 1 AND 15. During the same period patient was treated with CISPLATIN, BEVACIZUMAB, ZOFRAN, DEXAMETHASONE, LORAZEPAM, METOCLOPRAMIDE, ATIVAN. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #4611171-6
Gemzar side effect was reported by a Consumer or non-health professional from on May 06, 2004. Female patient, 63 years of age, weighting 90.39 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, oedema peripheral. Gemzar dosage: unknown. During the same period patient was treated with XANAX, DECADRON SRC, NEULASTA. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5324837-X
Gemzar side effect was reported by a Physician from HUNGARY on May 04, 2007. Female patient, 59 years of age, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, constipation
, decubitus ulcer, disease progression, dysphagia, dyspnoea, insomnia. Gemzar dosage: 2000 MG, UNK. During the same period patient was treated with CISPLATIN, METHYLPREDNISOLONE, RANITIDINE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 02/10/2007.Gemzar Side Effects Report #5371741-7
Gemzar side effect was reported by a Physician from HUNGARY on June 21, 2007. Female patient, 59 years of age, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, urticaria. Gemzar dosage: 2000 MG, UNK. During the same period patient was treated with CISPLATIN, METHYLPREDNISOLONE, RANITIDINE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 02/10/2007.
Gemzar Side Effects Report #4848076-1
Gemzar side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 16, 2005. Female patient, 44 years of age, weighting 110.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, disease progression, fatigue, granulocytopenia, syncope, thrombocytopenia. Gemzar dosage: 1560 MG, OTHER, INTRAVENOUS. During the same period patient was treated with GRANISETRON, DEXAMETHASONE. Patient recovered.
Gemzar Side Effects Report #4777493-3
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 30, 2005. Male patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atrial flutter, cardiac failure congestive, cardiac tamponade, cardiotoxicity, disease progression, hypertension, hypothyroidism, pericardial effusion, pericarditis constrictive. Gemzar dosage: 750 MG/M2. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #4777399-X
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 30, 2005. Male patient, 37 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiac tamponade, chest pain
, disease progression, hypertension, hypotension, hypoxia, infection , lymphoma . Gemzar dosage: 1000 MG/M2. During the same period patient was treated with VINCRISTINE. Patient was hospitalized. Patient died.Gemzar Side Effects Report #5356233-3
Gemzar side effect was reported by a Physician from ICELAND on May 30, 2007. Female patient, 61 years of age, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, thrombotic microangiopathy. Gemzar dosage: unknown. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #5675433-6
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Male patient, 40 years of age, weighting 168.0 lb, was diagnosed with malignant neoplasm progression and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, fatigue, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with DOCETAXEL, OXYCONTIN, TYLENOL, AMBIEN. Patient recovered.
Gemzar Side Effects Report #4709906-7
Gemzar side effect was reported by a Health Professional from UNITED STATES on June 20, 2005. Female patient, 60 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, radiation skin injury, rash
, thermal burn. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.Gemzar Side Effects Report #5253410-7
Gemzar side effect was reported by a Physician from HUNGARY on Feb 16, 2007. Female patient, 59 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, disease progression, hospitalisation, nausea
, pericardial effusion, urticaria. Gemzar dosage: 2000 MG, UNK. During the same period patient was treated with CISPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS, BETALOC, QUAMATEL, NUTRIDRINK. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5608147-9
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 18, 2008. Male patient, 72 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, refractory anaemia, spinal cord compression. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEFITINIB. Patient died.
Gemzar Side Effects Report #4742100-2
Gemzar side effect was reported by a Physician from JAPAN on July 20, 2005. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with lung adenocarcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, disease progression, haemoptysis, oxygen saturation decreased, pneumocystis jiroveci pneumonia, pulmonary alveolar haemorrhage. Gemzar dosage: 1200 MG OTHER. During the same period patient was treated with PARAPLATIN, ALLOPURINOL, MAGNESIUM OXIDE HEAVY, AZUCURENIN S, ASPIRIN, ENALAPRIL MALEATE. Patient died.
Gemzar Side Effects Report #4565358-1
Gemzar side effect was reported by a Pharmacist from on Jan 07, 2005. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma, lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disease progression, dyspnoea, fibrosis, hypoxia, pneumonia
, pulmonary toxicity. Gemzar dosage: 1680 MG. During the same period patient was treated with TAXOTERE. Patient died on 12/13/2004.Gemzar Side Effects Report #5675282-9
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Male patient, 47 years of age, was diagnosed with colon cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, pulmonary toxicity. Gemzar dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.
Gemzar Side Effects Report #4992693-5
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 18, 2005. Female patient, 73 years of age, was diagnosed with cervix carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, pain
. Gemzar dosage: unknown. Patient recovered.Gemzar Side Effects Report #4681601-2
Gemzar side effect was reported by a Physician from on May 17, 2005. Female patient, 47 years of age, weighting 158.7 lb, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, disease progression, haemolytic uraemic syndrome, hypertension, nausea
, neurological examination abnormal, oedema, rash . Gemzar dosage: 1141 MG/M2. During the same period patient was treated with ZOMETA, DIPHENHYDRAMINE, ALOXI, DECADRON, INSULIN, LISINOPRIL, LOVASTATIN, SYNTHROID. Patient died on 04/15/2005.Gemzar Side Effects Report #5013882-X
Gemzar side effect was reported by a Health Professional from FRANCE on May 10, 2006. Female patient, 65 years of age, weighting 143.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arthritis
, blood lactate dehydrogenase increased, disease progression, eyelid oedema, haemolytic uraemic syndrome, lung infection, metabolic acidosis, oedema peripheral. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4674466-6
Gemzar side effect was reported by a Physician from on May 04, 2005. Female patient, 47 years of age, weighting 158.7 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, disease progression, haemolysis, haemolytic uraemic syndrome, hypertension, nausea
, oedema. Gemzar dosage: 1141 MG/M2. During the same period patient was treated with ZOMETA, DIPHENHYDRAMINE, ALOXI, DECADRON, INSULIN, LISINOPRIL, LOVASTATIN, SYNTHROID. Patient died.Gemzar Side Effects Report #5728823-7
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Apr 28, 2008. Female patient, 45 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, pneumonitis. Gemzar dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.
Gemzar Side Effects Report #5475964-8
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient, 66 years of age, was diagnosed with breast cancer
, nausea and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, thrombosis, tumour marker increased. Gemzar dosage: unknown. During the same period patient was treated with ANTIEMETICS AND ANTINAUSEANTS. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5016323-1
Gemzar side effect was reported by a Physician from JAPAN on May 15, 2006. Male patient, 78 years of age, was diagnosed with bladder cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood pressure decreased, bone marrow failure, c-reactive protein increased, cardiac arrest , cerebral infarction, depressed level of consciousness, disease progression, disseminated intravascular coagulation. Gemzar dosage: 2500 MG/M2, INTRAVENOUS. During the same period patient was treated with PACLITAXEL. Patient died on 05/01/2006.Gemzar Side Effects Report #6132212-3
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 17, 2009. Male patient, weighting 168.0 lb, was diagnosed with biliary cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, disease progression, no therapeutic response, pulmonary embolism
, thrombosis. Gemzar dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5142744-2
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Female patient, 59 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression. Gemzar dosage: 1790 MG INTRAVENOUS. During the same period patient was treated with OXYCONTIN, PAXIL, DURAGESIC. Patient was hospitalized. Patient died on 08/17/2006.
Gemzar Side Effects Report #5984075-4
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Nov 27, 2008. Female patient, 36 years of age, was diagnosed with adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: convulsion, disease progression. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, TARCEVA, TAXOTERE. Patient recovered.
Gemzar Side Effects Report #6077715-5
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Feb 09, 2009. Female patient, 35 years of age, weighting 253.5 lb, was diagnosed with adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bile duct cancer, convulsion, disease progression. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, TARCEVA, TAXOTERE, DEXAMETHASONE, KEPPRA, VALPROATE. Patient was hospitalized and became disabled. Patient died.
Gemzar Side Effects Report #4938613-0
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2006. Female patient, 67 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, disease progression, hypoxia, pneumonia
, pyrexia, respiratory disorder. Gemzar dosage: 2000 MG. Patient was hospitalized. Patient died.Gemzar Side Effects Report #5356281-3
Gemzar side effect was reported by a Physician from ICELAND on May 30, 2007. Female patient, 65 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, thrombotic microangiopathy. Gemzar dosage: unknown. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #4951182-4
Gemzar side effect was reported by a Physician from AUSTRALIA on Mar 03, 2006. Female patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, embolic stroke, lung infection, lung neoplasm malignant, neutropenia, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, DEXAMETHASONE, VITAMIN B12. Patient was hospitalized. Patient died on 12/13/2005.
Gemzar Side Effects Report #4954762-5
Gemzar side effect was reported by a Physician from AUSTRALIA on Mar 03, 2006. Female patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, disease progression, embolic stroke, neutropenia, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, DEXAMETHASONE, VITAMIN 12. Patient was hospitalized. Patient died on 12/13/2005.
Gemzar Side Effects Report #4954770-4
Gemzar side effect was reported by a Physician from AUSTRALIA on Mar 03, 2006. Female patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, infection
, lung neoplasm malignant, neutropenia, pleural effusion, therapeutic response decreased, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, DEXAMETHASONE, VITAMIN B12. Patient was hospitalized. Patient died on 12/13/2005.Gemzar Side Effects Report #5356208-4
Gemzar side effect was reported by a Physician from ICELAND on May 30, 2007. Female patient, 59 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, renal failure chronic, thrombotic microangiopathy. Gemzar dosage: unknown. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #6045477-3
Gemzar side effect was reported by a Physician from TURKEY on Jan 12, 2009. Female patient, 59 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, disease progression. Gemzar dosage: 900 MG/M2, OVER 90 MIN ON DAY 1 AND 8. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #4771173-6
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 30, 2005. Female patient, 31 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac tamponade, disease progression, dyspnoea exertional, heart sounds abnormal, hypotension, leukaemia, lymphoma
, palpitations. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient died.Gemzar Side Effects Report #4777479-9
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 30, 2005. Female patient, 26 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiac tamponade, disease progression, hodgkin's disease
, lymphadenopathy, pericardial effusion, pericarditis constrictive, pulmonary hypertension , recall phenomenon. Gemzar dosage: 750 MG/M2. During the same period patient was treated with RITUXIMAB, VINCRISTINE. Patient was hospitalized. Patient died.Gemzar Side Effects Report #4646778-3
Gemzar side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, weighting 232.0 lb, was treated with Gemzar. After drug was administered, patient experienced the following side effects: dehydration, disease progression, feeding tube complication, haemodynamic instability, intestinal obstruction, respiratory failure. Gemzar dosage: unknown. During the same period patient was treated with REGLAN, VIOKASE, METFORMIN, LANTIS, ASPIRIN. Patient died on 04/20/2005.